The mortar had ripped through the hall’s canvas roof and sprayed shrapnel in every direction. Compared to others, Turner was ...

Dark genome therapeutics market is poised for robust growth through 2035, driven by increasing demand for personalized medicine and genomic advances.

This systematic review summarizes the literature examining the possible clinical benefits of EDTA chelation therapy in patients with preexistent cardiovascular disease. This is the largest review to ...

Given the high prevalence of substance use disorders, we are also carefully screening for such symptoms, as the impact of ...

Therapy is an excellent treatment for PTSD. The therapies that have been studied and proven effective include Prolonged ...

STRATA Skin Sciences, Inc. (NASDAQ: SSKN) announced significant progress in its mission to provide broader access to advanced ...

If regulators clear the application, the firm will begin a Phase I/II trial for RJVA-001 to assess its safety, tolerability, and initial efficacy.

This phase 3, randomised, double-blind, placebo-controlled trial included 407 participants with pre-existing or high risk for ASCVD with LDL cholesterol concentrations of 70 mg/dL or greater despite ...

OpenAI announced on Friday it’s launching a research preview of Codex, the company’s most capable AI coding agent yet. Codex is powered by codex-1, a version of the company’s o3 AI reasoning ...

The researchers described the unprecedented speed of the oversight steps as being "through alternative procedures." In month ...

An infant in Philadelphia has been successfully treated with a customized Crispr gene-editing therapy for a rare and deadly disease, doctors reported Thursday—a breakthrough in the futuristic ...

OpenAI has launched a new agentic coding tool with the potential to make even the most fresh-faced code monkey a software superstar. Codex, which the company announced on Thursday, represents a ...